Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Xiamen Amoytop Biotech CoSHSE:688278 -0.11%75 5-Year Yield-on-Cost % is 29.92 as of Sep. 07, 2026, which is 197% above its 10-year median of 10.06. GuruFocus rates SHSE:688278 with a GF Score™ of 75/100 and a GF Value™ of ¥106.87 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 148 Biotechnology companies, Xiamen Amoytop Biotech Co ranks better than 98.65% on this metric.
The historical rank and industry rank for Xiamen Amoytop Biotech Co's 5-Year Yield-on-Cost % or its related term are showing as below:
SHSE:688278'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.82 Med: 10.06 Max: 31.82
Current: 29.92
During the past 10 years, Xiamen Amoytop Biotech Co's highest Yield on Cost was 31.82. The lowest was 0.82. And the median was 10.06.
SHSE:688278's 5-Year Yield-on-Cost % is ranked better than 98.65% of 148
companies
in the Biotechnology industry
Industry Median: 1.585
vs SHSE:688278: 29.92
Xiamen Amoytop Biotech Co (SHSE:688278) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Xiamen Amoytop Biotech Co 5-Year Yield-on-Cost % Related Terms
SHSE:688278 vs VRTX, REGN, MRNA: 5-Year Yield-on-Cost % Comparison
For the Biotechnology subindustry, Xiamen Amoytop Biotech Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xiamen Amoytop Biotech Co 5-Year Yield-on-Cost % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Xiamen Amoytop Biotech Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Xiamen Amoytop Biotech Co's 5-Year Yield-on-Cost % falls into.
Xiamen Amoytop Biotech Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Xiamen Amoytop Biotech Co (SHSE:688278) has a 5-Year Yield-on-Cost % of 29.92 as of Sep. 07, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Xiamen Amoytop Biotech Co and its competitors. This is 197% above median its historical median of 10.06. Over the past decade, Xiamen Amoytop Biotech Co's 5-Year Yield-on-Cost % has ranged from 0.82 to 31.82. According to the industry distribution chart, Xiamen Amoytop Biotech Co ranks #2 out of 148 companies in the Biotechnology industry, placing it in the top 1.4%.
Is Xiamen Amoytop Biotech Co's 5-Year Yield-on-Cost % too high?
Xiamen Amoytop Biotech Co's current 5-Year Yield-on-Cost % of 29.92 is 197% above median its 10-year median of 10.06. Over the past 10 years, this metric has ranged from a low of 0.82 to a high of 31.82. The Biotechnology industry median 5-Year Yield-on-Cost % is 1.59. Xiamen Amoytop Biotech Co's value of 29.92 is 1787.7% above this industry median. Based on the distribution chart, Xiamen Amoytop Biotech Co ranks #2 out of 148 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Xiamen Amoytop Biotech Co has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Xiamen Amoytop Biotech Co's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Xiamen Amoytop Biotech Co ranks #2 out of 148 companies for 5-Year Yield-on-Cost %. This places Xiamen Amoytop Biotech Co in the top 1% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 1.59. Xiamen Amoytop Biotech Co's value of 29.92 is 1787.7% above this benchmark. Historically, Xiamen Amoytop Biotech Co's own 5-Year Yield-on-Cost % has ranged from 0.82 to 31.82 over the past decade. While the company's 10-year median is 10.06 vs. the industry median of 1.59, Xiamen Amoytop Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.59, based on 148 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xiamen Amoytop Biotech Co's current 5-Year Yield-on-Cost % of 29.92 is 1787.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Xiamen Amoytop Biotech Co and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xiamen Amoytop Biotech Co's current 5-Year Yield-on-Cost % is 29.92, which is 197% above median its own 10-year median of 10.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xiamen Amoytop Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Xiamen Amoytop Biotech Co (SHSE:688278) is currently considered Possible Value Trap. The stock's GF Value™ is ¥106.87, compared to a current price of ¥56.90 — trading 46.8% below its estimated fair value. The current 5-Year Yield-on-Cost % is 29.92, which is 197% above median its 10-year median of 10.06 and 1787.7% above the Biotechnology industry median of 1.59. Xiamen Amoytop Biotech Co's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Xiamen Amoytop Biotech Co (SHSE:688278), the current 5-Year Yield-on-Cost % is 29.92 as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Xiamen Amoytop Biotech Co (SHSE:688278) Overvalued in 2026?
Based on GuruFocus' analysis, Xiamen Amoytop Biotech Co stock appears to be undervalued.
The current stock price of ¥56.90 is trading 46.8% below its estimated GF Value™ of ¥106.87.
GuruFocus considers Xiamen Amoytop Biotech Co to be Possible Value Trap.
Key valuation signals for SHSE:688278:
5-Year Yield-on-Cost %: 29.92 (197% above median its 10-year median of 10.06)
GF Value™: ¥106.87 vs. price of ¥56.90 (46.8% below fair value)
Industry Position: 1787.7% above the Biotechnology median (#2 of 148)
No single metric tells the full story. See the SHSE:688278 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Xiamen Amoytop Biotech Co Ltd operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products.
75GF Score
Get the complete analysis for SHSE:688278
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688278 has been successfully added to your 
